Current clinical applications of RNA-LNPs in cancer: a promising horizon for targeted therapies.
作者信息
Hussain Md Sadique, Khan Gyas
机构信息
Uttaranchal Institute of Pharmaceutical Sciences, Uttaranchal University, Prem Nagar, Dehradun 248007, Uttarakhand, India.
Department of Pharmacology and Toxicology, College of Pharmacy, Jazan University, Jazan 45142, Saudi Arabia.
出版信息
EXCLI J. 2025 Feb 27;24:321-324. doi: 10.17179/excli2025-8132. eCollection 2025.
Abstract
摘要
相似文献
1
Current clinical applications of RNA-LNPs in cancer: a promising horizon for targeted therapies.RNA脂质纳米颗粒在癌症中的当前临床应用：靶向治疗的前景广阔。
EXCLI J. 2025 Feb 27;24:321-324. doi: 10.17179/excli2025-8132. eCollection 2025.
2
Developing Biodegradable Lipid Nanoparticles for Intracellular mRNA Delivery and Genome Editing.用于细胞内 mRNA 递送和基因组编辑的可生物降解脂质纳米粒子的开发。
Acc Chem Res. 2021 Nov 2;54(21):4001-4011. doi: 10.1021/acs.accounts.1c00500. Epub 2021 Oct 20.
3
Lipid nanoparticles (LNPs) for in vivo RNA delivery and their breakthrough technology for future applications.用于体内 RNA 递送的脂质纳米颗粒 (LNPs) 及其未来应用的突破性技术。
Adv Drug Deliv Rev. 2023 Sep;200:114990. doi: 10.1016/j.addr.2023.114990. Epub 2023 Jul 7.
4
Advances in Lipid Nanoparticle-Based Disease Treatment.基于脂质纳米颗粒的疾病治疗进展。
ChemMedChem. 2025 May 5;20(9):e202400938. doi: 10.1002/cmdc.202400938. Epub 2025 Feb 17.
5
Unleashing the Power of Proenzyme Delivery for Targeted Therapeutic Applications Using Biodegradable Lipid Nanoparticles.利用可生物降解脂质纳米粒释放酶原用于靶向治疗应用。
Acc Chem Res. 2024 Jan 16;57(2):208-221. doi: 10.1021/acs.accounts.3c00597. Epub 2023 Dec 24.
6
Advancements and challenges in mRNA and ribonucleoprotein-based therapies: From delivery systems to clinical applications.基于mRNA和核糖核蛋白的疗法的进展与挑战：从递送系统到临床应用
Mol Ther Nucleic Acids. 2024 Aug 19;35(3):102313. doi: 10.1016/j.omtn.2024.102313. eCollection 2024 Sep 10.
7
Encapsulation of Dexamethasone into mRNA-Lipid Nanoparticles Is a Promising Approach for the Development of Liver-Targeted Anti-Inflammatory Therapies.将地塞米松包封入 mRNA-脂质纳米颗粒是开发肝脏靶向抗炎疗法的一种很有前途的方法。
Int J Mol Sci. 2024 Oct 19;25(20):11254. doi: 10.3390/ijms252011254.
8
Chemistry of Lipid Nanoparticles for RNA Delivery.脂质纳米颗粒的 RNA 递送化学。
Acc Chem Res. 2022 Jan 4;55(1):2-12. doi: 10.1021/acs.accounts.1c00544. Epub 2021 Dec 1.
9
Lipid Nanoparticle (LNP) Chemistry Can Endow Unique RNA Delivery Fates within the Liver That Alter Therapeutic Outcomes in a Cancer Model.脂质纳米颗粒 (LNP) 化学可赋予肝脏内独特的 RNA 递药命运，从而改变癌症模型中的治疗效果。
Mol Pharm. 2022 Nov 7;19(11):3973-3986. doi: 10.1021/acs.molpharmaceut.2c00442. Epub 2022 Sep 26.
10
A robust post-insertion method for the preparation of targeted siRNA LNPs.一种用于制备靶向性siRNA脂质纳米颗粒的强大的插入后方法。
Int J Pharm. 2022 May 25;620:121741. doi: 10.1016/j.ijpharm.2022.121741. Epub 2022 Apr 11.
引用本文的文献
1
Transition Temperature-Guided Design of Lipid Nanoparticles for Effective mRNA Delivery.用于有效mRNA递送的脂质纳米颗粒的转变温度引导设计
ACS Appl Mater Interfaces. 2025 May 14;17(19):28012-28024. doi: 10.1021/acsami.5c06464. Epub 2025 May 5.
本文引用的文献
1
Advances in mRNA LNP-Based Cancer Vaccines: Mechanisms, Formulation Aspects, Challenges, and Future Directions.基于mRNA脂质纳米颗粒的癌症疫苗进展：作用机制、制剂方面、挑战及未来方向
J Pers Med. 2024 Nov 4;14(11):1092. doi: 10.3390/jpm14111092.
2
Single immunizations of self-amplifying or non-replicating mRNA-LNP vaccines control HPV-associated tumors in mice.单次免疫自扩增或非复制型 mRNA-LNP 疫苗可控制小鼠的 HPV 相关肿瘤。
Sci Transl Med. 2023 Mar 8;15(686):eabn3464. doi: 10.1126/scitranslmed.abn3464.
3
Lipid nanoparticle-mediated lymph node-targeting delivery of mRNA cancer vaccine elicits robust CD8 T cell response.脂质纳米颗粒介导的 mRNA 癌症疫苗淋巴结靶向递送引发强烈的 CD8 T 细胞反应。
Proc Natl Acad Sci U S A. 2022 Aug 23;119(34):e2207841119. doi: 10.1073/pnas.2207841119. Epub 2022 Aug 15.
4
Current Status and Future Perspectives on MRNA Drug Manufacturing.信使核糖核酸药物制造的现状与未来展望
Mol Pharm. 2022 Apr 4;19(4):1047-1058. doi: 10.1021/acs.molpharmaceut.2c00010. Epub 2022 Mar 3.
5
Chemistry of Lipid Nanoparticles for RNA Delivery.脂质纳米颗粒的 RNA 递送化学。
Acc Chem Res. 2022 Jan 4;55(1):2-12. doi: 10.1021/acs.accounts.1c00544. Epub 2021 Dec 1.
6
Activation of PPARγ Inhibits TLR4 Signal Transduction Pathway in Melanoma Cancer .过氧化物酶体增殖物激活受体γ（PPARγ）的激活抑制黑色素瘤中的Toll样受体4（TLR4）信号转导通路 。
Adv Pharm Bull. 2020 Jul;10(3):458-463. doi: 10.34172/apb.2020.056. Epub 2020 May 11.
7
mRNA Delivery for Therapeutic Anti-HER2 Antibody Expression In Vivo.mRNA 递送至体内治疗性抗 HER2 抗体表达。
Mol Ther. 2019 Aug 7;27(8):1415-1423. doi: 10.1016/j.ymthe.2019.05.012. Epub 2019 May 18.
8
Broadening the Message: A Nanovaccine Co-loaded with Messenger RNA and α-GalCer Induces Antitumor Immunity through Conventional and Natural Killer T Cells.拓宽信息：一种共载信使 RNA 和 α-半乳糖神经酰胺的纳米疫苗通过常规和自然杀伤 T 细胞诱导抗肿瘤免疫。
ACS Nano. 2019 Feb 26;13(2):1655-1669. doi: 10.1021/acsnano.8b07660. Epub 2019 Feb 15.
9
Lipid nanoparticles that deliver IL-12 messenger RNA suppress tumorigenesis in MYC oncogene-driven hepatocellular carcinoma.递送 IL-12 信使 RNA 的脂质纳米颗粒抑制 MYC 癌基因驱动的肝细胞癌发生。
J Immunother Cancer. 2018 Nov 20;6(1):125. doi: 10.1186/s40425-018-0431-x.
10
Cationic lipid-assisted nanoparticles for delivery of mRNA cancer vaccine.阳离子脂质体辅助纳米颗粒递送 mRNA 癌症疫苗。
Biomater Sci. 2018 Nov 1;6(11):3009-3018. doi: 10.1039/c8bm00908b. Epub 2018 Sep 28.
Zotero 插件